Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Pinato, D.J
928  Ergebnisse:
Personensuche X
?
1

Sleep characteristics in children with attention deficit hy..:

Miranda de Souza, A.L. Decanini ; Giacheti, C.M. ; Couto, M.C.H....
Sleep Medicine.  115 (2024)  - p. S240 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Language development and sleep quality in children with Con..:

Silva, N. ; Ribeiro, E. ; Couto, M.C....
Sleep Medicine.  115 (2024)  - p. S5 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Sleep disordered in children who stutter: a descriptive ana..:

Couto, M.C.H. ; Oliveira, C.M.C. ; Silva, N.C....
Sleep Medicine.  115 (2024)  - p. S240 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Sleep quality characterization of individuals with cerebral..:

Meneses da Silva, I. ; Helena do Couto, M.C. ; Cristina da Silva, N....
Sleep Medicine.  115 (2024)  - p. S136 , 2024
Link: https://doi.org/10.1016/..
 
?
5

T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATE..:

Celsa, C. ; Cabibbo, G. ; Fulgenzi, C.A.M....
Digestive and Liver Disease.  56 (2024)  - p. S255 , 2024
Link: https://doi.org/10.1016/..
 
?
6

112P Measuring time-toxicity and prognostic impact of hospi..:

Awosika, N.O. ; Maleki, A. ; Mehan, A....
ESMO Open.  9 (2024)  - p. 102337 , 2024
Link: https://doi.org/10.1016/..
 
?
7

111P Characteristics and outcomes of immunotherapy-related ..:

Celsa, C. ; Cabibbo, G. ; Marron, T.U....
Immuno-Oncology and Technology.  20 (2023)  - p. 100583 , 2023
Link: https://doi.org/10.1016/..
 
?
8

159TiP Two phase I studies assessing the safety and efficac..:

Berz, D. ; Pinato, D.J. ; Barve, M....
Immuno-Oncology and Technology.  20 (2023)  - p. 100670 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Learning lessons from the COVID-19 pandemic for real-world ..:

Castelo-Branco, L. ; Lee, R. ; Brandão, M....
ESMO Open.  8 (2023)  4 - p. 101596 , 2023
Link: https://doi.org/10.1016/..
 
?
10

114TiP Preliminary assessment of safety and tolerability of..:

Fulgenzi, C.A.M. ; Dalla Pria, A. ; Bower, M.D..
ESMO Open.  8 (2023)  1 - p. 101151 , 2023
Link: https://doi.org/10.1016/..
 
?
11

Taxonomic reclassification of Kaposi Sarcoma identifies dis..:

Openshaw, M. R. ; Gervasi, E. ; Fulgenzi, C. A. M....
Journal of Translational Medicine.  21 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
12

134P A phase I study exploring the safety and tolerability ..:

Pinato, D.J. ; Banerji, U. ; Rottey, S....
Immuno-Oncology and Technology.  20 (2023)  - p. 100606 , 2023
Link: https://doi.org/10.1016/..
 
?
13

96P The Hammersmith score optimises patient selection and p..:

Korolewicz, J.A. ; Scheiner, B. ; Fulgenzi, C....
ESMO Open.  8 (2023)  1 - p. 100954 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Atezolizumab plus bevacizumab versus lenvatinib or sorafeni..:

Rimini, M. ; Rimassa, L. ; Ueshima, K....
ESMO Open.  7 (2022)  6 - p. 100591 , 2022
Link: https://doi.org/10.1016/..
 
?
15

OA07.06 Second Line Treatment Outcomes After Progression on..:

Auclin, E. ; Benitez-Montanez, J. ; Gorria, T....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S22 , 2022
Link: https://doi.org/10.1016/..
 
1-15